TY - JOUR
T1 - 1, 25-dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets
AU - Matsui, Toshimitsu
AU - Nakao, Yoshinobu
AU - Koizumi, Tamio
AU - Nakagawa, Toshitaro
AU - Fujita, Takuo
PY - 1985/7/8
Y1 - 1985/7/8
N2 - The biologically active vitamin D metabolite, 1,25-(OH)2D3 suppressed phytohaemagglutinin (PHA)-induced lymphocyte proliferation dose-dependently (0.1 nM-100nM), and decreased the OKT4+/OKT8+ ratio and transferrin-receptor-positive (OKT9+) cells. A possible parallelism between expression of 1,25-(OH) 2D3 receptors and interleukin 2 (IL2)-receptors recognized by anti-Tac antibody was not confirmed in this study. However, the addition of exogenous IL2 abolished the inhibitory effects of 1,25-(OH) 2D3 on PHA-stimulated T-cell proliferation, and the decrease of OKT4+ and OKT9+ T-cell in this population. Among various vitamin D3 analogues examined, 1,25-(OH) 2D3 was the most potent antiproliferative effect, followed in order by 1,24S-(OH) 2D3, 1α OH D3, 25 OH D3 and 24, 25-(OH) 2D3.
AB - The biologically active vitamin D metabolite, 1,25-(OH)2D3 suppressed phytohaemagglutinin (PHA)-induced lymphocyte proliferation dose-dependently (0.1 nM-100nM), and decreased the OKT4+/OKT8+ ratio and transferrin-receptor-positive (OKT9+) cells. A possible parallelism between expression of 1,25-(OH) 2D3 receptors and interleukin 2 (IL2)-receptors recognized by anti-Tac antibody was not confirmed in this study. However, the addition of exogenous IL2 abolished the inhibitory effects of 1,25-(OH) 2D3 on PHA-stimulated T-cell proliferation, and the decrease of OKT4+ and OKT9+ T-cell in this population. Among various vitamin D3 analogues examined, 1,25-(OH) 2D3 was the most potent antiproliferative effect, followed in order by 1,24S-(OH) 2D3, 1α OH D3, 25 OH D3 and 24, 25-(OH) 2D3.
UR - https://www.scopus.com/pages/publications/0021888713
U2 - 10.1016/0024-3205(85)90630-7
DO - 10.1016/0024-3205(85)90630-7
M3 - Article
C2 - 2989641
AN - SCOPUS:0021888713
SN - 0024-3205
VL - 37
SP - 95
EP - 101
JO - Life Sciences
JF - Life Sciences
IS - 1
ER -